Stacy D. D’Andre

1.4k total citations
23 papers, 304 citations indexed

About

Stacy D. D’Andre is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Stacy D. D’Andre has authored 23 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Pharmacology. Recurrent topics in Stacy D. D’Andre's work include Cannabis and Cannabinoid Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Stacy D. D’Andre is often cited by papers focused on Cannabis and Cannabinoid Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). Stacy D. D’Andre collaborates with scholars based in United States, Japan and Italy. Stacy D. D’Andre's co-authors include T. R. Wandzilak, Paul A. Davis, Hibbard E. Williams, Richard L. Schilsky, Elizabeth Garrett‐Mayer, Susan Halabi, R. Gupta, Pam K. Mangat, Daniel J. Sargent and T Buroker and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Stacy D. D’Andre

19 papers receiving 294 citations

Peers

Stacy D. D’Andre
Gareth Beynon United Kingdom
Fundagül Andiç Türkiye
Kellie L. Jones United States
RM Tamimi United States
Eva Malířová Czechia
Meng Hua Tao United States
P Rudziński Poland
Andaç Argon Türkiye
K Miyai Japan
Seungyoun Jung United States
Gareth Beynon United Kingdom
Stacy D. D’Andre
Citations per year, relative to Stacy D. D’Andre Stacy D. D’Andre (= 1×) peers Gareth Beynon

Countries citing papers authored by Stacy D. D’Andre

Since Specialization
Citations

This map shows the geographic impact of Stacy D. D’Andre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy D. D’Andre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy D. D’Andre more than expected).

Fields of papers citing papers by Stacy D. D’Andre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy D. D’Andre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy D. D’Andre. The network helps show where Stacy D. D’Andre may publish in the future.

Co-authorship network of co-authors of Stacy D. D’Andre

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy D. D’Andre. A scholar is included among the top collaborators of Stacy D. D’Andre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy D. D’Andre. Stacy D. D’Andre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jatoi, Aminah, Kathryn J. Ruddy, Jacob J. Orme, et al.. (2025). Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors. Journal of Pain and Symptom Management. 70(2). 182–188.
2.
Lapid, Maria I., Sandeep R. Pagali, Kristine A. Donovan, et al.. (2025). Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review. Palliative & Supportive Care. 23. e99–e99. 1 indexed citations
3.
Vierkant, Robert A., Daniela Stan, Dawn M. Mussallem, et al.. (2025). Association between alcohol intake and health-related quality of life in breast cancer survivors.. Journal of Clinical Oncology. 43(16_suppl). 11114–11114.
4.
Davis, Mellar P., A. Ulrich, Rebecca Segal, et al.. (2024). Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study. Cancers. 16(24). 4244–4244.
5.
Acosta, Andrés, et al.. (2024). Weight-centric prevention of cancer. PubMed. 10. 100106–100106. 1 indexed citations
6.
D’Andre, Stacy D., et al.. (2024). Cancer and Stress: Understanding the Connections and Interventions. American Journal of Lifestyle Medicine. 19(8). 1193–1215. 5 indexed citations
7.
8.
Ghusn, Wissam, Stacy D. D’Andre, Stephanie S. Faubion, et al.. (2023). FRI077 Efficacy Of Anti-obesity Medications Among Breast Cancer Survivors Taking Aromatase Inhibitors. Journal of the Endocrine Society. 7(Supplement_1). 3 indexed citations
9.
Webb, Mason, Terry C. Burns, Erin Twohy, et al.. (2023). Efficacy and safety study of neoadjuvant efineptakin alfa (NT-I7) and pembrolizumab in recurrent glioblastoma.. Journal of Clinical Oncology. 41(16_suppl). TPS2085–TPS2085. 3 indexed citations
10.
D’Andre, Stacy D., et al.. (2022). Dietary supplement use and recommendations for discontinuation in an integrative oncology clinic. Supportive Care in Cancer. 31(1). 40–40.
11.
Gupta, R., Funda Meric‐Bernstam, Michael Rothe, et al.. (2022). Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer WithERBB2Amplification orERBB2/3Mutations: Results From the TAPUR Study. JCO Precision Oncology. 6(6). e2200306–e2200306. 38 indexed citations
12.
13.
D’Andre, Stacy D., et al.. (2021). Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series. Integrative Cancer Therapies. 20. 1543376875–1543376875. 18 indexed citations
14.
Pisick, Evan, Michael Rothe, Pam K. Mangat, et al.. (2021). Palbociclib (P) in patients (pts) with head and neck cancer (HNC) with CDKN2A loss or mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. 39(15_suppl). 6043–6043. 3 indexed citations
15.
Liu, Joyce F., Mark F. Brady, Ursula A. Matulonis, et al.. (2020). A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.. Journal of Clinical Oncology. 38(15_suppl). 6003–6003. 45 indexed citations
16.
Behl, Deepti, Stacy D. D’Andre, & Carol Parise. (2020). Patterns of use of medical cannabis in a community oncology clinic.. Journal of Clinical Oncology. 38(15_suppl). e24111–e24111. 2 indexed citations
17.
El-Khoueiry, Anthony B., Syma Iqbal, D. A. Singh, et al.. (2006). A randomized phase II non-comparative study of Ispinesib given weekly or every three weeks in metastatic colorectal cancer. A California Cancer Consortium Study (CCC-P). Journal of Clinical Oncology. 24(18_suppl). 3595–3595. 9 indexed citations
18.
D’Andre, Stacy D., Daniel J. Sargent, S. Stephen, et al.. (2005). 5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study. Clinical Colorectal Cancer. 4(5). 325–331. 36 indexed citations
19.
Wandzilak, T. R., Stacy D. D’Andre, Paul A. Davis, & Hibbard E. Williams. (1994). Effect of High Dose Vitamin C on Urinary Oxalate Levels. The Journal of Urology. 151(4). 834–837. 83 indexed citations
20.
Wandzilak, T. R., et al.. (1992). Oxalate transport in cultured porcine renal epithelial cells. Urological Research. 20(5). 341–345. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gareth Beynon Breakdown of academic impact, for papers by Fundagül Andiç Breakdown of academic impact, for papers by Kellie L. Jones Breakdown of academic impact, for papers by RM Tamimi Breakdown of academic impact, for papers by Eva Malířová Breakdown of academic impact, for papers by Meng Hua Tao Breakdown of academic impact, for papers by P Rudziński Breakdown of academic impact, for papers by Andaç Argon Breakdown of academic impact, for papers by K Miyai Breakdown of academic impact, for papers by Seungyoun Jung
Rankless by CCL
2026